REFERENCES
- Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann Med 1990; 22: 57–9.
- Nord CE, Lidbeck A, Orrhage K, Sjöstedt S. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin. Clin Microbiol Infect 1997; 3: 124–32.
- Orrhage K, Sjöstedt S, Nord CE. Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother (in press).
- Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995; 49: 346–52.
- Lee Y-K, Salminen S. The coming age of probiotics. Trends in Food Science & Technology 1995; 6: 241–5.
- Linden PK, Miller CB. Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbiol Infect Dis 1999; 33: 113–20.
- Segal-Maurer S, Urban C, Rahal JJ Jr. Current perspectives on multidrug-resistant bacteria. Infect Dis Clin North Am 1996; 10: 939–57.
- Melhus Å, Tjernberg I. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1996; 28: 191–3.
- Torell E, Fredlund H, Törnquist E, Myhre EB, Sjöberg L, Sundsfjord A. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1997; 29: 259–63.
- Torell E, Cars O, Olsson-Liljequist B, Hoffman BM, Lindback J, Burman LG. Near absence of vancomycin-resistant entero- cocci but high carriage rates of quinolone-resistant ampicillin- resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol 1999; 37: 3509–13.
- Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H. Glycopeptide susceptibility among Danish Ente- rococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother 1996; 40: 1938–40.
- Poulsen RL, Pallesen LV, Frimodt-Moller N, Espersen F. Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization. APMIS 1999; 107: 404–12.
- Edlund C, Beyer G, Hiemer-Bau M, Ziege S, Lode H, Nord CE. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis 2000; 32: 81–5.
- Mackay A, Taylor M, Kibbler C, Hamilton-Miller J. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5: 290–2.
- Fredenucci I, Chomarat M, Boucaud C, Flandrois JP. Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin Infect Dis 1998; 27: 222–3.
- Lidbeck A, Gustafsson J-A, Nord CE. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1987; 19: 531–7.
- Sepp E, Mikelsaar M, Salminen S. Effect of administration of Lactobacillus casei strains GG on the intestinal microbiota of newborns. Microb Ecology Health Dis 1993; 6: 309–14.
- Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997; 25: 729–32.
- Wegener HC. Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited. Antimicrob Agents Chemother 1998; 42: 502–8.
- van den Bogaard AE, Jensen LB, Stobberingh EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558–9.
- Bogo Jensen L, Hammerum AM, Lykke Poulsen R, Westh H. Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob Agents Chemother 1999; 43: 724–5.